Covered recipient · General Payments record
POORNIMA KAUL
General Payments · PY2019–2025
$1,857.98
- Reported across 71 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $327.68 | 16 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| MILLICENT US INC | $68.14 | 3 |
| Biogen, Inc. | $52.54 | 2 |
| PFIZER INC. | $42.05 | 2 |
| Astellas Pharma US Inc | $40.80 | 2 |
| CooperSurgical, Inc. | $32.37 | 2 |
| Exeltis, USA Inc. | $24.99 | 1 |
| Amgen Inc. | $24.35 | 1 |
| Hologic Sales and Service, LLC | $23.46 | 1 |
| Organon LLC | $14.30 | 1 |
| MAYNE PHARMA COMMERCIAL LLC | $4.68 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (16)
Sorted by paying entity, then date · as published by CMS
Program year 2025 20192021202220232024
Record-level detail is published for PY2025; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $24.35 | 10/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228305791 | CMS |
| Astellas Pharma US Inc | $21.69 | 01/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238575591 | CMS |
| Astellas Pharma US Inc | $19.11 | 03/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238575593 | CMS |
| Biogen, Inc. | $28.62 | 02/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1208459458 | CMS |
| Biogen, Inc. | $23.92 | 05/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1208483554 | CMS |
| CooperSurgical, Inc. | $15.38 | 02/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1241746270 | CMS |
| CooperSurgical, Inc. | $16.99 | 10/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1241746318 | CMS |
| Exeltis, USA Inc. | $24.99 | 12/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1218196431 | CMS |
| Hologic Sales and Service, LLC | $23.46 | 10/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1182585385 | CMS |
| MAYNE PHARMA COMMERCIAL LLC | $4.68 | 12/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1254268006 | CMS |
| MILLICENT US INC | $20.63 | 03/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235198189 | CMS |
| MILLICENT US INC | $22.83 | 04/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235198191 | CMS |
| MILLICENT US INC | $24.68 | 05/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235198193 | CMS |
| Organon LLC | $14.30 | 01/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1237658810 | CMS |
| PFIZER INC. | $20.36 | 08/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1229738564 | CMS |
| PFIZER INC. | $21.69 | 11/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1230943765 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2021, 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.